IRF1 and cancer: In HRAS transformed murine fibroblasts, and RAS-transformed human cancer cells, MEK-ERK signaling was shown to negatively regulate IRF-1-dependent transcription of IRF1 and STAT2 [13,14], thus hampering IFN responses, and supporting the replication of oncolytic vesicular stomatitis virus (VSV).